Stephen Worland

Stephen Worland

Founder at
eFFECTOR Therapeutics Operations, Inc.
68 year
Health Technology
Consumer Services
Technology Services

Profile

Stephen T.
Worland
is the founder of eFFECTOR Therapeutics Operations, Inc., founded in 2012, where the title held is President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer & Director at Numerion Labs, Inc. since 2025, and Director at Blacksmith Medicines, Inc. since 2017.
Former jobs include President, Chief Executive Officer & Director at Anadys Pharmaceuticals, Inc. from 2007 to 2011; President, Chief Executive Officer & Director at eFFECTOR Therapeutics, Inc. from 2021 to 2024; VP-Antiviral Research & Director-Molecular Biology at Agouron Pharmaceuticals LLC from 1988 to 2001; Independent Non-Executive Director at GenMark Diagnostics, Inc. from 2013 to 2015; Director at Forge Therapeutics, Inc.; Independent Director at TRACON Pharmaceuticals, Inc. from 2015 to 2024; Vice President & Head-Antiviral Research at Pfizer Inc. from 2000 to 2001; and Vice President at Warner-Lambert Co. Education includes a doctorate from the University of California, Berkeley, and an undergraduate degree from the University of Michigan.

Stephen Worland active positions

CompaniesPositionStart
Founder 30/04/2012
Director/Board Member 31/03/2017
Chief Executive Officer 17/02/2025

Former positions of Stephen Worland

CompaniesPositionEnd
TRACON PHARMACEUTICALS, INC. Director/Board Member 30/07/2024
EFFECTOR THERAPEUTICS, INC. Chief Executive Officer 20/06/2024
GENMARK DIAGNOSTICS, INC. Director/Board Member 31/01/2015
Chief Executive Officer 22/11/2011
Corporate Officer/Principal 31/12/2000
See the detail of Stephen Worland's experience

Training of Stephen Worland

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Stephen Worland